Tizanidine
Product Images NDC 50436-0251

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-0251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

This is a graph showing the comparison of the mean concentration of tizanidine in tablets and capsules under fed and fasted conditions.*

FDA Label Image

Figure-2.jpg (Figure 2)

This is a graph showing the mean change in muscle tone from baseline as measured by the Ashworth Scale in a single dose study. The graph displays the hours post-dose on the X-axis and the change in muscle tone on the Y-axis. The negative Ashworth score signifies an improvement in muscle tone from baseline. The graph includes a 95% confidence interval.*

FDA Label Image

Figure-3.jpg (Figure 3)

FDA Label Image

Label Image (Lbl504360251)

This is a medication package for Tizanidine Hydrochloride, containing 30 tablets of 2mg strength each. Each tablet contains 1o mg tzanidine base and 2268 mg aanidine hydrochloride equivalent. It is manufactured by Apotex Inc. in Toronto, Ontario, Canada, and the manufacturing NDC is 60505-0251-3. The package provides a lot number and an expiration date. There are instructions to dispense in a tight, resistant container and store at room temperature, and also provide a dosage information insert.*

FDA Label Image

Label Image (Lbl504360252)

This text is a medication label for Tizanidine Hydrochloride tablets manufactured by Apotex Inc in Toronto, Canada. Each bottle contains 30 tablets, with each tablet containing 4mg of Tizanidine Hydrochloride. The medication is designed to treat muscle spasms and can only be obtained with a prescription. The label provides cautionary information advising users to keep the medication out of reach of children and to store it at a controlled room temperature between 20.25°C - 66.77°F. The package insert contains dosage information. Lot and expiration information are also provided.*

FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.